McLaren J, Prentice A, Charnock-Jones D S, Smith S K
Department of Obstetrics and Gynaecology, University of Cambridge, Clinical School, Rosie Maternity Hospital, Robinson Way, Cambridge CB2 2SW, UK.
Hum Reprod. 1996 Jan;11(1):220-3. doi: 10.1093/oxfordjournals.humrep.a019023.
Active endometriosis is characterized by hypervascularization both within and surrounding the implant; therefore the presence of angiogenic factors in the peritoneal environment would be of great importance. Vascular endothelial growth factor (VEGF) is a potent angiogenic factor involved in both physiological and pathological angiogenesis. We sought to determine if VEGF was present in the peritoneal fluid of women with and without endometriosis, and to establish if differences exist between these groups. VEGF was present in all patients sampled. The fluid from patients with endometriosis contained significantly greater amounts of VEGF than controls. Cyclic variations in VEGF concentration were seen in fluid from patients with endometriosis, the VEGF concentration in proliferative phase being significantly higher than in the secretory phase. The concentration of VEGF in this fluid was also significantly higher than that found in the proliferative and secretory phases of women without endometriosis. No cyclic variations in VEGF were seen in the control group. We suggest that elevated levels of VEGF in the peritoneal fluid of patients with endometriosis may be critical in the pathogenesis of endometriosis.
活跃期子宫内膜异位症的特征是植入物内部及其周围血管增生;因此,腹膜环境中血管生成因子的存在至关重要。血管内皮生长因子(VEGF)是一种强效血管生成因子,参与生理和病理血管生成过程。我们试图确定VEGF是否存在于患有和未患有子宫内膜异位症的女性的腹水中,并确定这些组之间是否存在差异。所有采样患者的腹水中均存在VEGF。子宫内膜异位症患者的腹水所含VEGF量明显高于对照组。子宫内膜异位症患者腹水中可见VEGF浓度的周期性变化,增殖期的VEGF浓度明显高于分泌期。该腹水中VEGF的浓度也明显高于未患子宫内膜异位症女性的增殖期和分泌期。对照组未观察到VEGF的周期性变化。我们认为,子宫内膜异位症患者腹水中VEGF水平升高可能在子宫内膜异位症的发病机制中起关键作用。